Study type: Human research · Status: Verified against declared source
Cerebrolysin as a New Treatment Option for Post-Stroke Spasticity: Patient and Physician Perspectives
2019
Study scale: Taking into account the small number of centers and insufficient number of specialists providing quality rehabilitative treatment in our country, the access to this type of care is limited.
Abstract only: Open source record
Product or molecular entity relationships
- Cerebrolysin: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.
Plain-language verified summary
Question
Not reported in the reviewed source.
Methods
Not reported in the reviewed source.
Scale or participants
Taking into account the small number of centers and insufficient number of specialists providing quality rehabilitative treatment in our country, the access to this type of care is limited.
Key findings
Recent studies show that spasticity occurs in 20–30% of all stroke victims, especially in younger patients.
Limitations and uncertainty
Recent studies show that spasticity occurs in 20–30% of all stroke victims, especially in younger patients.
Verified against declared source. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.